Literature DB >> 27068648

A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants.

Naoya Fukushima1, Kenji Nanao2, Hiroyuki Fukushima3, Akira Namera4, Masaru Miura5.   

Abstract

UNLABELLED: It is known that tricyclic antidepressants induce long QT intervals associated with forms of life-threatening arrhythmia such as torsades de pointes (TdP), and these adverse effects may also occur in neonates whose mothers take tricyclic antidepressants. We report a neonatal case of prolonged QT interval and TdP caused by clomipramine that was transferred transplacentally from the mother. Administration of magnesium sulfate was effective to abolish TdP.
CONCLUSION: When mothers take tricyclic antidepressants during pregnancy, their newborns should be watched carefully for drug-induced long QT syndrome and TdP. WHAT IS KNOWN: •Tricyclic antidepressant can prolong the QT interval. It may be used for depression in pregnancy. What is New: •This is the first neonatal case report of prolonged QT interval and TdP caused by clomipramine transferred transplacentally from the mother.

Entities:  

Keywords:  Clomipramine; Desmethylclomipramine; Placental passage; Prolonged QT interval; Torsades de Pointes

Mesh:

Substances:

Year:  2016        PMID: 27068648     DOI: 10.1007/s00431-016-2722-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

Review 1.  Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Monica E Kleinman; Leon Chameides; Stephen M Schexnayder; Ricardo A Samson; Mary Fran Hazinski; Dianne L Atkins; Marc D Berg; Allan R de Caen; Ericka L Fink; Eugene B Freid; Robert W Hickey; Bradley S Marino; Vinay M Nadkarni; Lester T Proctor; Faiqa A Qureshi; Kennith Sartorelli; Alexis Topjian; Elise W van der Jagt; Arno L Zaritsky
Journal:  Circulation       Date:  2010-11-02       Impact factor: 29.690

2.  Prevalence of the congenital long-QT syndrome.

Authors:  Peter J Schwartz; Marco Stramba-Badiale; Lia Crotti; Matteo Pedrazzini; Alessandra Besana; Giuliano Bosi; Fulvio Gabbarini; Karine Goulene; Roberto Insolia; Savina Mannarino; Fabio Mosca; Luigi Nespoli; Alessandro Rimini; Enrico Rosati; Patrizia Salice; Carla Spazzolini
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

3.  Placental passage of tricyclic antidepressants.

Authors:  Ada M Loughhead; Zachary N Stowe; D Jeffrey Newport; James C Ritchie; C Lindsay DeVane; Michael J Owens
Journal:  Biol Psychiatry       Date:  2005-11-02       Impact factor: 13.382

4.  Clomipramine concentration and withdrawal symptoms in 10 neonates.

Authors:  Peter G J ter Horst; Susanne van der Linde; Jan Pieter Smit; Jan den Boon; Richard A van Lingen; Frank G A Jansman; Lolkje T W De Jong-van den Berg; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

5.  Prenatal diagnosis of a long QT syndrome by fetal magnetocardiography in an unshielded bedside environment.

Authors:  Uwe Schneider; Jens Haueisen; Markus Loeff; Nikolai Bondarenko; Ekkehard Schleussner
Journal:  Prenat Diagn       Date:  2005-08       Impact factor: 3.050

6.  Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers.

Authors:  S Kaseda; R F Gilmour; D P Zipes
Journal:  Am Heart J       Date:  1989-09       Impact factor: 4.749

7.  Prolongation of the QT interval and the sudden infant death syndrome.

Authors:  P J Schwartz; M Stramba-Badiale; A Segantini; P Austoni; G Bosi; R Giorgetti; F Grancini; E D Marni; F Perticone; D Rosti; P Salice
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

Review 8.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  The bioavailability of oral and parenteral chlorimipramine (Anafranil).

Authors:  L E Evans; J H Bett; J R Cox; J P Dubois; T Van Hees
Journal:  Prog Neuropsychopharmacol       Date:  1980

10.  Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.

Authors:  Su-Hyun Jo; Hee-Kyung Hong; Seon Ha Chong; Kwang Hee Won; Sung Jun Jung; Han Choe
Journal:  Eur J Pharmacol       Date:  2008-07-02       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.